As mentioned in my Seeking Alpha profile, I'm a long-term investor, but I also sometimes trade short-term opportunities. The fact that I'm discussing Anacor Pharmaceuticals (NASDAQ:ANAC) from the short-term opportunity perspective does not mean that I consider the stock unsuitable for long-term investment. In fact, I only cover stocks that have potential to evolve into long-term investments.
The scope of this article is limited since I am not a pharmacologist or physician and do not have deep insight into the medical viability of developmental-stage pharmaceuticals. Thus, the article scope is to offer updates on ANAC from my first article on the company. It is not to speculate on the medical viability or potential FDA approval...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|